Cappella Release: New Bifurcation Stent System Provides Breakthrough In Treatment Of Ostial-Bifurcated Lesions

AUBURNDALE, Mass.--(BUSINESS WIRE)--Cappella Inc. announced today the successful implantation of its Sideguard™ dedicated side branch stents in two patients. The procedures were performed by Professor Eberhard Grube, MD, Chief of Cardiology and Angiology at the Heart Center Siegburg, Germany.
MORE ON THIS TOPIC